Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

internal diagnostics

  • Home
  •  
  • internal diagnostics



  • Most Read
  • Latest Comments
  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Mach7 completes largest renewal program in its history with DocPanel
    Mach7 completes largest renewal program in its history with DocPanel
    • News

  • Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    • News

  • Cyclopharm gets FDA green light to sell its lung imaging tech Technegas in the US
    Cyclopharm gets FDA green light to sell its lung imaging tech Technegas in the US
    • News

  • IMEXHS seals the deal with Colombia’s fifth largest health insurer
    IMEXHS seals the deal with Colombia’s fifth largest health insurer
    • News

  • IDX revenue remains steady despite ongoing spicy flu woes
    IDX revenue remains steady despite ongoing spicy flu woes
    • News

  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    IDX revenue remains steady despite ongoing spicy flu woes

    As one of Australia’s leading providers of medical imaging and diagnostic services, Integral Diagnostics (ASX: IDX) plays a vital role in supporting clinicians to provide optimal treatment for their patients. With 67 radiology clinics under their umbrella, IDX is a prominent provider of radiology services to multiple communities across Western Victoria, Queensland, Western Australia and

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.